216 related articles for article (PubMed ID: 18172301)
41. Y-box binding protein 1--a prognostic marker and target in tumour therapy.
Kosnopfel C; Sinnberg T; Schittek B
Eur J Cell Biol; 2014; 93(1-2):61-70. PubMed ID: 24461929
[TBL] [Abstract][Full Text] [Related]
42. The epithelial-mesenchymal transition-inducing factor TWIST is an attractive target in advanced and/or metastatic bladder and prostate cancers.
Wallerand H; Robert G; Pasticier G; Ravaud A; Ballanger P; Reiter RE; Ferrière JM
Urol Oncol; 2010; 28(5):473-9. PubMed ID: 19272800
[TBL] [Abstract][Full Text] [Related]
43. MAPK and PI3K/AKT mediated YB-1 activation promotes melanoma cell proliferation which is counteracted by an autoregulatory loop.
Sinnberg T; Sauer B; Holm P; Spangler B; Kuphal S; Bosserhoff A; Schittek B
Exp Dermatol; 2012 Apr; 21(4):265-70. PubMed ID: 22417301
[TBL] [Abstract][Full Text] [Related]
44. Twist is required for thrombin-induced tumor angiogenesis and growth.
Hu L; Roth JM; Brooks P; Ibrahim S; Karpatkin S
Cancer Res; 2008 Jun; 68(11):4296-302. PubMed ID: 18519689
[TBL] [Abstract][Full Text] [Related]
45. The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1.
Astanehe A; Finkbeiner MR; Hojabrpour P; To K; Fotovati A; Shadeo A; Stratford AL; Lam WL; Berquin IM; Duronio V; Dunn SE
Oncogene; 2009 Jun; 28(25):2406-18. PubMed ID: 19430491
[TBL] [Abstract][Full Text] [Related]
46. Down regulation of Akirin-2 increases chemosensitivity in human glioblastomas more efficiently than Twist-1.
Krossa S; Schmitt AD; Hattermann K; Fritsch J; Scheidig AJ; Mehdorn HM; Held-Feindt J
Oncotarget; 2015 Aug; 6(25):21029-45. PubMed ID: 26036627
[TBL] [Abstract][Full Text] [Related]
47. Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction.
Wu Y; Wang KY; Li Z; Liu YP; Izumi H; Uramoto H; Nakayama Y; Ito K; Kohno K
J Exp Clin Cancer Res; 2014 Dec; 33(1):112. PubMed ID: 25539742
[TBL] [Abstract][Full Text] [Related]
48. [Molecular mechanism of the stress induction of MDR1 gene].
Kohno K
Nihon Rinsho; 1997 May; 55(5):1054-8. PubMed ID: 9155152
[TBL] [Abstract][Full Text] [Related]
49. Twist confers chemoresistance to anthracyclines in bladder cancer through upregulating P-glycoprotein.
Chen Y; Li L; Zeng J; Wu K; Zhou J; Guo P; Zhang D; Xue Y; Liang L; Wang X; Chang LS; He D
Chemotherapy; 2012; 58(4):264-72. PubMed ID: 22986993
[TBL] [Abstract][Full Text] [Related]
50. Y-box binding protein-1 and STAT3 independently regulate ATP-binding cassette transporters in the chemoresistance of gastric cancer cells.
Chua PJ; Lim JP; Guo TT; Khanna P; Hu Q; Bay BH; Baeg GH
Int J Oncol; 2018 Dec; 53(6):2579-2589. PubMed ID: 30221675
[TBL] [Abstract][Full Text] [Related]
51. Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2.
Wu J; Lee C; Yokom D; Jiang H; Cheang MC; Yorida E; Turbin D; Berquin IM; Mertens PR; Iftner T; Gilks CB; Dunn SE
Cancer Res; 2006 May; 66(9):4872-9. PubMed ID: 16651443
[TBL] [Abstract][Full Text] [Related]
52. Mutual regulation between Raf/MEK/ERK signaling and Y-box-binding protein-1 promotes prostate cancer progression.
Imada K; Shiota M; Kohashi K; Kuroiwa K; Song Y; Sugimoto M; Naito S; Oda Y
Clin Cancer Res; 2013 Sep; 19(17):4638-50. PubMed ID: 23838318
[TBL] [Abstract][Full Text] [Related]
53. Twist and p53 reciprocally regulate target genes via direct interaction.
Shiota M; Izumi H; Onitsuka T; Miyamoto N; Kashiwagi E; Kidani A; Hirano G; Takahashi M; Naito S; Kohno K
Oncogene; 2008 Sep; 27(42):5543-53. PubMed ID: 18504427
[TBL] [Abstract][Full Text] [Related]
54. Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy.
Stratford AL; Habibi G; Astanehe A; Jiang H; Hu K; Park E; Shadeo A; Buys TP; Lam W; Pugh T; Marra M; Nielsen TO; Klinge U; Mertens PR; Aparicio S; Dunn SE
Breast Cancer Res; 2007; 9(5):R61. PubMed ID: 17875215
[TBL] [Abstract][Full Text] [Related]
55. PDGFRα and β play critical roles in mediating Foxq1-driven breast cancer stemness and chemoresistance.
Meng F; Speyer CL; Zhang B; Zhao Y; Chen W; Gorski DH; Miller FR; Wu G
Cancer Res; 2015 Feb; 75(3):584-93. PubMed ID: 25502837
[TBL] [Abstract][Full Text] [Related]
56. An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells.
Garand C; Guay D; Sereduk C; Chow D; Tsofack SP; Langlois M; Perreault E; Yin HH; Lebel M
Cancer Sci; 2011 Jul; 102(7):1410-7. PubMed ID: 21466612
[TBL] [Abstract][Full Text] [Related]
57. Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance.
To K; Fotovati A; Reipas KM; Law JH; Hu K; Wang J; Astanehe A; Davies AH; Lee L; Stratford AL; Raouf A; Johnson P; Berquin IM; Royer HD; Eaves CJ; Dunn SE
Cancer Res; 2010 Apr; 70(7):2840-51. PubMed ID: 20332234
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of the multidrug-resistant phenotype by targeting YB-1 with a conditionally oncolytic adenovirus: implications for combinatorial treatment regimen with chemotherapeutic agents.
Mantwill K; Köhler-Vargas N; Bernshausen A; Bieler A; Lage H; Kaszubiak A; Surowiak P; Dravits T; Treiber U; Hartung R; Gansbacher B; Holm PS
Cancer Res; 2006 Jul; 66(14):7195-202. PubMed ID: 16849566
[TBL] [Abstract][Full Text] [Related]
59. Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer.
Mabe NW; Fox DB; Lupo R; Decker AE; Phelps SN; Thompson JW; Alvarez JV
J Clin Invest; 2018 Oct; 128(10):4413-4428. PubMed ID: 30148456
[TBL] [Abstract][Full Text] [Related]
60. Identification of a novel function of TWIST, a bHLH protein, in the development of acquired taxol resistance in human cancer cells.
Wang X; Ling MT; Guan XY; Tsao SW; Cheung HW; Lee DT; Wong YC
Oncogene; 2004 Jan; 23(2):474-82. PubMed ID: 14724576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
